---
title: "GSK Highlights Lung Cancer Data From Two Drugs — STAT+ Briefing"
id: "stat-news-0-stat-gsk-touts-lung-cancer-data-from-two-drugs"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-gsk-touts-lung-cancer-data-from-two-drugs"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/14/biotech-news-gsk-touts-lung-cancer-data-from-two-drugs/?utm_campaign=rss"
published_at: "2026-09-14T13:34:37.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# GSK Highlights Lung Cancer Data From Two Drugs — STAT+ Briefing
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-gsk-touts-lung-cancer-data-from-two-drugs
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/09/14/biotech-news-gsk-touts-lung-cancer-data-from-two-drugs/?utm_campaign=rss)
- **Published At:** 2026-09-14T13:34:37.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Article headline: **GSK** touts **lung cancer** data from two drugs; published by Meghana Keshavan on Sept. 14, 2026 for STAT News. - The story is presented as a STAT+ exclusive and the full article is paywalled; the provided source contains only the headline, author, date, image, and a short teaser but not the detailed results. - Teaser items in the source reference other biotech items: late-stage results for Definium’s LSD therapy in anxiety, an AstraZeneca breast cancer drug failing a key trial, and concerns that certain drugmaker deals could undermine “most-favored nation” Medicare savings. - The source includes human-interest aside and site navigation content but does not publish numerical trial outcomes, trial names, patient populations, endpoints, or regulatory implications for GSK’s lung cancer data. - The source identifies this item as part of The Readout newsletter and places it among other biotech headlines and STAT+ subscriber content. - Key facts that are not present in the provided text and therefore unavailable from this source: which GSK drugs were discussed, trial phase details, efficacy or safety results, comparator arms, statistical significance, regulatory plans, or any direct quotes from company executives or investigators. - Because the source is incomplete, readers are directed to the STAT+ paywall for the full reporting; the extracted content should be treated as a pointer rather than a complete report of clinical data.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/09/14/biotech-news-gsk-touts-lung-cancer-data-from-two-drugs/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/09/14/biotech-news-gsk-touts-lung-cancer-data-from-two-drugs/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [Medicaid](https://www.statnews.com/topic/medicaid/) [CMS](https://www.statnews.com/topic/cms/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)Newsletter[The Readout](https://www.statnews.com/category/readout-newsletter/) # GSK touts lung cancer data from two drugs ## Late-stage results for Definium’s LSD treatment, AstraZeneca breast cancer drug fails key trial, and more biotech news from The Readout * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/09/14/biotech-news-gsk-touts-lung-cancer-data-from-two-drugs/?utm_campaign=rss) ![The GlaxoSmithKline office building with its logo is shown through a blurred foreground of tree leaves -- coverage from STAT](https://www.statnews.com/wp-content/uploads/2024/12/GettyImages-1345341627-645x645.jpg) Leon Neal/Getty Images ![](https://www.statnews.com/wp-content/uploads/2021/02/meghana-k-avatar-small2-80x80.png) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) Sept. 14, 2026 Biotech Correspondent ![](https://www.statnews.com/wp-content/uploads/2021/02/meghana-k-avatar-small2-80x80.png) [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) 1. [](https://x.com/megkesh "X") meghana.keshavan@statnews.com Meghana Keshavan covers biotech and contributes to [The Readout newsletter](https://www.statnews.com/signup/readout/). _Want to stay on top of the science and politics driving biotech today?[Sign up](https://www.statnews.com/signup/readout/) to get our biotech newsletter in your inbox._ Definium’s LSD therapy has a strong performacne in a pivotal anxiety trial, drugmaker deals could gut “most-favored nation” Medicare savings, and more. Advertisement In this endless heat wave my house is now overrun with flies and I think I give up and will also become a fly. They win. STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [drug development](https://www.statnews.com/topic/drug-development/), [Drug prices](https://www.statnews.com/topic/drug-prices/), [research](https://www.statnews.com/topic/research/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/meghana-k-avatar-small2-80x80.png) [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) 1. [](https://x.com/megkesh "X") 2. Biotech Correspondent 1. [](https://x.com/megkesh "X") 2. Meghana Keshavan covers biotech and contributes to [The Readout newsletter](https://www.statnews.com/signup/readout/). ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black-640x295.png) ### Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/09/daniel-ruralhealth2-3-80x80.jpg) [The GOP’s $50 billion rural health fund is coming up short, hospital leaders say](https://www.statnews.com/2026/09/14/rural-health-transformation-fund-skepticism-shortcomings-part-5-unraveled-series/) 2. ![](https://www.statnews.com/wp-content/uploads/2018/07/donald-trump-drug-prices-GettyImages-963722188-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests](https://www.statnews.com/pharmalot/2026/09/13/trump-secretive-pharma-deals-undermine-most-favored-nation-pricing/) 3. ![](https://www.statnews.com/wp-content/uploads/2016/09/Infusion_AP_328963423903-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Scholar Rock wins FDA approval for first drug to target SMA muscle loss](https://www.statnews.com/2026/09/11/scholar-rock-spinal-muscular-atrophy-isembyld-clinical-trial-fda-approval/) 4. ![](https://www.statnews.com/wp-content/uploads/2025/12/GettyImages-2245790195-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [What’s in a name? Novo looks to a rebrand](https://www.statnews.com/2026/09/14/novo-nordisk-company-rebrand-obesity-diabetes/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_1085203947_Editorial_Use_Only-80x80.jpeg) [Medicaid will let states use ‘tiers’ to determine medical frailty ](https://www.statnews.com/2026/09/11/medicaid-work-requirements-new-tier-system-define-medical-frailty/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/01/heart-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation](https://www.statnews.com/2026/09/07/novo-nordisk-heart-studies-inflammation-ziltivekimab/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Screenshot-2026-09-10-at-11.16.19-AM-e1789064257681-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field](https://www.statnews.com/2026/09/11/novartis-novo-nordisk-cardiovascular-drug-trials-fallout/) 3. ![](https://www.statnews.com/wp-content/uploads/2016/09/Infusion_AP_328963423903-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Scholar Rock wins FDA approval for first drug to target SMA muscle loss](https://www.statnews.com/2026/09/11/scholar-rock-spinal-muscular-atrophy-isembyld-clinical-trial-fda-approval/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/09/Lindsay_Clancy_Trial_8_1_1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Lindsay Clancy case exposes dangers of fragmented U.S. health system, experts say](https://www.statnews.com/2026/09/04/lindsay-clancy-health-care-silos-postpartum-care-failures/) 5. ![](https://www.statnews.com/wp-content/uploads/2023/04/AdobeStock_521699065_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals](https://www.statnews.com/pharmalot/2026/09/08/fda-warns-api-supplier-residue-corroded-production-line-sandals/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech September 14, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Definium’s LSD therapy eased anxiety in second large trial ](https://www.statnews.com/2026/09/14/definiums-lsd-therapy-eased-anxiety-large-trial-psychedelic/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech September 11, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Scholar Rock wins FDA approval for first drug to target SMA muscle loss ](https://www.statnews.com/2026/09/11/scholar-rock-spinal-muscular-atrophy-isembyld-clinical-trial-fda-approval/) By [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout September 11, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Cancer drug shortages keep disrupting patient care ](https://www.statnews.com/2026/09/11/biotech-news-cancer-drug-shortages-keep-disrupting-patient-care/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD September 11, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field ](https://www.statnews.com/2026/09/11/novartis-novo-nordisk-cardiovascular-drug-trials-fallout/) By [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) and [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout September 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA expands Bayer lung cancer drug approval ](https://www.statnews.com/2026/09/10/biotech-news-fda-expands-bayer-lung-cancer-drug-approval/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field ](https://www.statnews.com/2026/09/11/novartis-novo-nordisk-cardiovascular-drug-trials-fallout/) By [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) and [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: What to expect from UniQure's upcoming Huntington's gene therapy readout ](https://www.statnews.com/2026/09/10/uniqure-huntingtons-gene-therapy-trial-readout/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Inhibrx claims first win for long-sought immunotherapy target ](https://www.statnews.com/2026/09/08/inhibrx-inbrx-106-ox40-immunotherapy-head-and-neck-cancer-hpv-positive/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Lindsay Clancy case exposes dangers of fragmented U.S. health system, experts say ](https://www.statnews.com/2026/09/04/lindsay-clancy-health-care-silos-postpartum-care-failures/) By [Tara Bannow](https://www.statnews.com/staff/tara-bannow/) 5. ### [ Trump officials say AI will help save rural health care. Some leaders in the field don’t believe it ](https://www.statnews.com/2026/09/10/rural-health-care-ai-adoption-challenges-pa
## Related Clinical Research

- [Sen. Warren demands access to Trump drug-pricing contracts, accuses RFK Jr. of concealing them](https://medichelpline.com/clinical-feed/stat-news-0-stat-sen-warren-demands-to-see-trump-drug-pricing-pharma-contracts-accuses-rfk.md)
- [Obesity drugmakers are beginning pediatric trials in children as young as 6](https://medichelpline.com/clinical-feed/stat-news-1-stat-obesity-drugmakers-are-testing-in-kids-as-young-as-6.md)
- [Daraxonrasib shows activity in RAS‑mutant NSCLC after FDA approval in pancreatic cancer](https://medichelpline.com/clinical-feed/medical-news-today-0-pancreatic-cancer-drug-may-also-help-fight-treatment-resistant-lung-cancer.md)
- [Link Between Daily Sugary Drink Consumption and Increased Stomach Cancer Risk](https://medichelpline.com/clinical-feed/medical-news-today-1-daily-sugary-drink-consumption-linked-to-more-than-double-stomach-cancer-risk.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.